Department of Microbiology, Pondicherry University, Puducherry, 605014, India.
Curtin Malaysia Research Institute, Curtin University, CDT 250, 98009, Miri, Sarawak, Malaysia.
Fish Shellfish Immunol. 2021 May;112:92-107. doi: 10.1016/j.fsi.2021.02.018. Epub 2021 Mar 4.
Penaeus vannamei is one of the most economically vital shrimp globally, but infectious diseases have hampered its proper production and supply. As antibiotics pose a huge threat to the environment and humankind, it is essential to seek an alternative strategy to overcome infection and ensure proper culture and production. The present study investigates the effect of an anti-infective biosurfactant derivative lipopeptide MSA31 produced by a marine bacterium on the growth performance, disease resistance, and the gut microbiome of P. vannamei when challenged with pathogenic Vibrio parahaemolyticus SF14. The shrimp were fed with a commercial and lipopeptide formulated diet for 60 days and the growth performance was analyzed. The lipopeptide fed shrimp group showed enhanced growth performance and specific growth rate with improved weight gain than the control group. The challenge experiment showed that the survival rate was significant in the lipopeptide fed group compared to the control group. The results revealed 100% mortality in the control group at the end of 12 h of challenge, while 50% of the lipopeptide diet-fed group survived 24 h, which indicates the enhanced disease resistance in shrimp fed with a lipopeptide diet. The test group also showed higher levels of digestive and immune enzymes, which suggests that the lipopeptide diet could positively modulate the digestive and immune activity of the shrimp. The gut microbiome profiling by Illumina high-throughput sequencing revealed that the most abundant genera in the lipopeptide diet-fed group were Adhaeribacter, Acidothermus, Brevibacillus, Candidatus, Mycobacterium, Rodopila, and Streptomyces, while opportunistic pathogens such as Streptococcus, Escherichia, Klebsiella, Neisseria, Rhizobium, and Salmonella were abundant in the control diet-fed shrimp. Also, lipopeptide diet-fed shrimp were found to have a high abundance of ammonia and nitrogen oxidizing bacteria, which are essential pollutant degraders. Therefore, the study reveals that the dietary supplementation of lipopeptide in shrimp aquaculture could positively modulate the gut microbiome and enhance the shrimp's overall health and immunity in an eco-friendly manner.
凡纳滨对虾是全球最重要的经济虾类之一,但传染性疾病严重阻碍了其正常的生产和供应。由于抗生素对环境和人类构成巨大威胁,因此寻找一种替代策略来克服感染并确保适当的养殖和生产至关重要。本研究调查了一种由海洋细菌产生的抗感染生物表面活性剂衍生的脂肽 MSA31 对凡纳滨对虾在受到致病性副溶血弧菌 SF14 挑战时的生长性能、抗病能力和肠道微生物组的影响。将虾用商业饲料和脂肽饲料喂养 60 天,并分析其生长性能。结果表明,与对照组相比,脂肽喂养组的生长性能得到了显著提高,表现为增重提高和特定生长率提高。攻毒实验表明,与对照组相比,脂肽喂养组的存活率显著提高。结果表明,对照组在攻毒 12 小时后全部死亡,而脂肽饮食组有 50%的虾在 24 小时后存活,这表明喂食脂肽的虾的抗病能力增强。实验组还表现出更高水平的消化和免疫酶,这表明脂肽饮食可以积极调节虾的消化和免疫活性。Illumina 高通量测序的肠道微生物组分析表明,在脂肽饮食组中丰度最高的属为 Adhaeribacter、Acidothermus、Brevibacillus、Candidatus、Mycobacterium、Rodopila 和 Streptomyces,而机会致病菌如链球菌、大肠杆菌、克雷伯菌、奈瑟菌、根瘤菌和沙门氏菌在对照组中丰度较高。此外,在脂肽饮食喂养的虾中发现氨氮和氮氧化细菌的丰度较高,这些细菌是必不可少的污染物降解菌。因此,本研究表明,在虾养殖中补充脂肽可以以生态友好的方式积极调节肠道微生物组,并增强虾的整体健康和免疫力。